A. van Rensen

Anergic T cells actively suppress T cell responses via the antigen‐presenting cell

W. van Eden, M. Wauben, M. Poelen, 1998, European journal of immunology.

Induction of T Cell Anergy by Liposomes with Incorporated Major Histocompatibility Complex (MHC) II/Peptide Complexes

W. van Eden, M. Wauben, D. Crommelin, 2000, Pharmaceutical Research.

Liposomes with Incorporated MHC Class Il/Peptide Complexes as Antigen Presenting Vesicles for Specific T Cell Activation

W. van Eden, M. Wauben, D. Crommelin, 1999, Pharmaceutical Research.

The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis

H. Voogdt-Pruis, A. van Rensen, Eva Vroonland, 2020, Frontiers in Medicine.

Modulation of Th2 Responses by Peptide Analogues in a Murine Model of Allergic Asthma: Amelioration or Deterioration of the Disease Process Depends on the Th1 or Th2 Skewing Characteristics of the Therapeutic Peptide1

W. van Eden, M. Wauben, E. Janssen, 2000, The Journal of Immunology.

Involving burn survivors in agenda setting on burn research: an added value?

M. Zweekhorst, J. Broerse, A. van Rensen, 2010, Burns : journal of the International Society for Burn Injuries.

Recommendations from a James Lind Alliance priority setting partnership - a qualitative interview study

K. Jongsma, A. Verwoerd, A. van Rensen, 2020, Research Involvement and Engagement.

Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol

S. Kamphuis, N. Wulffraat, J. Boer, 2018, Pediatric Rheumatology.

Liposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detection.

D. Crommelin, M. Wauben, G. Storm, 1999, Journal of controlled release : official journal of the Controlled Release Society.